The WHO issued a "road map" Thursday that "responds to the urgent need to dramatically scale up the international response" in light of the acceleration of new cases, it said.
The road map is based on an assumption that "in many areas of intense transmission the actual number of cases may be 2-4 fold higher than that currently reported," the document states.
An Ebola vaccine being developed by the U.S. National Institutes of Health and GlaxoSmithKline will be fast-tracked for human trials, the international consortium behind the effort said Thursday.
The WHO said Monday that 120 health care workers have died in the Ebola outbreak, and twice that number have been infected.
"Every day this outbreak goes on, it increases the risk for another export to another country.